Vanberra Signal

Morphoceuticals

Curated by Signal

Developer of ion-channel drugs to regenerate tissues and organs

Overview

Developer of ion-channel drugs to regenerate tissues and organs. The company is pioneering the bioelectric reprogramming of biology to treat complex health states by targeting native bioelectric signaling to reprogram biology that can regenerate tissues and organs, including the brain. It has applications for Amputation stump health, Limb regeneration, and Organogenesis.

Key facts

Founded
2020

Contact

Open roles

1 role
  • Research Associate – Ex Vivo Imaging (Temporary, 6+ Months)

    Medford, MA · On-site · Volunteer

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of prosthetic hands

    Life Sciences TechnologyLincoln, United States
  • Developer of emergency medical alert systems for senior care

    Life Sciences TechnologyWilliamsport, United States
  • Developer of microbiome-based therapies by using human-first discovery platform

    Life Sciences TechnologySomerville, United States

About Morphoceuticals

What does Morphoceuticals do?

Developer of ion-channel drugs to regenerate tissues and organs.

Where is Morphoceuticals headquartered?

Morphoceuticals is headquartered in Marblehead, United States.

When was Morphoceuticals founded?

Morphoceuticals was founded in 2020.

Which sector is Morphoceuticals in?

Morphoceuticals operates in Life Sciences Technology.

Who are Morphoceuticals's competitors?

Companies similar to Morphoceuticals include AION Prosthetics, Alert 1, and Finch Therapeutics.

Is Morphoceuticals hiring?

Yes. Morphoceuticals has 1 open role listed on Vanberra Signal.